Use of Transcranial Photobiomodulation to Improve Cognition and Self-Reported Outcomes in Survivors of Childhood Cancer

Exclusion Criteria

• •Estimated intelligence score less than 80.
• •Currently taking medication intended to treat neurocognitive impairment (i.e., stimulants).
• •Major psychiatric condition.
• •Alcohol abuse in the past year (AUDIT) \[greater than or equal to 13 for women and greater than or equal to 15 for men\]. The Alcohol Use Disorders Identification Test (AUDIT) will be used to screen for individuals who have active alcohol-use disorders.
• •Drug abuse in the past year (DAST-10) \[ greater than or equal to 3 for women or men\] The Drug Abuse Screen Test (DAST-10) will be used to screen for individuals with active drug abuse.
• •History of neurologic condition or genetic disorder associated with neurocognitive impairment unrelated to cancer diagnosis or treatment.
• •Enrolled on another independent cognitive intervention protocol within the last year.
• •Female participants who are pregnant or lactating (determined by participant self-report due to the remote nature of this study)
• •Tattoo or artificial marking in the area where the device will be positioned.